Cardinal Health (CAH) ended the recent trading session at $208.48, demonstrating a +1.47% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily gain ...

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2026 on February 5, prior ...

Cardinal Health stock is being upgraded to a buy rating, from my prior hold rating last year, agreeing with the SA analyst consensus today. Bullish drivers include recent revenue/earnings growth, ...

Cardinal Health, Inc. (NYSE:CAH) is included among the 20 Best Performing Dividend Stocks in 2025. Cardinal Health, Inc.

Feb 1 (Reuters) - Cardinal Health (CAH.N), opens new tab lowered the full-year profit forecast for its medical segment on Thursday, taking the shine off the company's upbeat second-quarter results and ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Cardinal Health (CAH) been one of those stocks this year? A quick glance at the ...

The Cordis medical device business that Cardinal Health bought for $1.9 billion is proving to be a millstone for the company. Cordis, a former Johnson & Johnson subsidiary, ran into a raft of ...

Cardinal Health is building another warehouse in central Ohio as the wholesale drug distribution and medical supply company builds out capacity for the distribution for over-the-counter consumer ...

The COVID-19 pandemic exposed critical flaws in hospital supply chains for vital equipment like ventilators and personal protective gear. Many health systems struggled with shortages and often ...

DUBLIN, Ohio, Feb. 9, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced it will leverage the Kinaxis® RapidResponse® platform to increase medical product visibility and supply chain ...

The drug and medical products distributor Cardinal Health plans to acquire Medtronic's medical supplies business for $6.1 billion, the company announced on Tuesday. The cash deal would give the Dublin ...

Drug distributor Cardinal Health Inc said on Friday it would sell its Cordis medical device business to private equity firm Hellman & Friedman in a deal valued at about $1 billion. Updates with ...